Robert Haseltine, son of Robert Haseltine and Joanna Swanne, was born 2 Jan 1609/10 in Knedlington, Howden, Yorkshire, England. He immigrated to America in 1638. He married Anna Langley on 23 Dec 1639 in Rowley, Massachusetts. Her parents are not listed. They had ten children. Robert died 27 Aug 1674 in Bradford, Massachusetts. Anna also died in Bradford on 26 July 1684. Their descendants have lived in Massachusetts, New Hampshire, Vermont, New York and other areas throughout the United States.
The Genealogy Annual is a comprehensive bibliography of the year's genealogies, handbooks, and source materials. It is divided into three main sections.p liFAMILY HISTORIES-/licites American and international single and multifamily genealogies, listed alphabetically by major surnames included in each book.p liGUIDES AND HANDBOOKS-/liincludes reference and how-to books for doing research on specific record groups or areas of the U.S. or the world.p liGENEALOGICAL SOURCES BY STATE-/liconsists of entries for genealogical data, organized alphabetically by state and then by city or county.p The Genealogy Annual, the core reference book of published local histories and genealogies, makes finding the latest information easy. Because the information is compiled annually, it is always up to date. No other book offers as many citations as The Genealogy Annual; all works are included. You can be assured that fees were not required to be listed.
The history of the CCR5 gene as a lens through which to view such issues as intellectual property, Big Pharma, personalized medicine, and race and genomics. In The Genealogy of a Gene, Myles Jackson uses the story of the CCR5 gene to investigate the interrelationships among science, technology, and society. Mapping the varied “genealogy” of CCR5—intellectual property, natural selection, Big and Small Pharma, human diversity studies, personalized medicine, ancestry studies, and race and genomics—Jackson links a myriad of diverse topics. The history of CCR5 from the 1990s to the present offers a vivid illustration of how intellectual property law has changed the conduct and content of scientific knowledge, and the social, political, and ethical implications of such a transformation. The CCR5 gene began as a small sequence of DNA, became a patented product of a corporation, and then, when it was found to be an AIDS virus co-receptor with a key role in the immune system, it became part of the biomedical research world—and a potential moneymaker for the pharmaceutical industry. When it was further discovered that a mutation of the gene found in certain populations conferred near-immunity to the AIDS virus, questions about race and genetics arose. Jackson describes these developments in the context of larger issues, including the rise of “biocapitalism,” the patentability of products of nature, the difference between U.S. and European patenting approaches, and the relevance of race and ethnicity to medical research.
